共 50 条
Bipolar Radiofrequency and Non-Crosslinked Hyaluronic Acid Plus Calcium Hydroxyapatite in the Treatment of Stress Urinary Incontinence
被引:0
|作者:
Kolczewski, Piotr
[1
]
Lukaszuk, Mariusz
[2
]
Cymbaluk-Ploska, Aneta
[1
]
Kozlowski, Mateusz
[1
]
Ciecwiez, Sylwester
[3
,4
]
Kuzlik, Rafal
[5
]
Zerbinati, Nicola
[6
]
机构:
[1] Pomeranian Med Univ, Dept Reconstruct Surg & Gynecol Oncol, Al Powstancow Wielkopolskich 72, PL-70111 Szczecin, Poland
[2] Nov Aesthet & Antiaging Med Private Clin, PL-80255 Gdansk, Poland
[3] Pomeranian Med Univ, Dept Gynecol Endocrinol & Gynecol Oncol, Ul Unii Lubelskiej 1, PL-71252 Szczecin, Poland
[4] Pomeranian Med Univ, Dept Perinatol Obstet & Gynecol, Ul Siedlecka 2, PL-72010 Police, Poland
[5] SaskaMed Clin, Ul Jana Nowaka Jezioranskiego 48, PL-03994 Warsaw, Poland
[6] Univ Insubria, Dept Med & Surg, I-21100 Varese, Italy
关键词:
stress urinary incontinence;
radiofrequency;
non-crosslinked hyaluronic acid;
calcium hydroxyapatite;
QUALITY-OF-LIFE;
VAGINAL LAXITY;
HYDROXYLAPATITE FILLER;
GENITOURINARY SYNDROME;
IMPACT QUESTIONNAIRE;
SEXUAL FUNCTION;
WOMEN;
THERAPY;
REJUVENATION;
MANAGEMENT;
D O I:
10.3390/ph17050622
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
Background: Stress urinary incontinence (SUI) causes both physical and psychological problems to women and their partners. Recently, vaginal radiofrequency (RF) application, as well as the administration of non-crosslinked hyaluronic acid (NCLHA) together with calcium hydroxyapatite (CaHA), has attracted attention for SUI treatment. The current, comparative study evaluated the efficacy and safety of these technologies acting separately and in a combined treatment. Methods: Sixty women with mild to moderate SUI, aged between 46 and 76 years (mean age 63.2) were divided into three groups intended for different treatments: group I, RF vaginal treatment only, group II, NCLHA plus CaHA periurethral injection only, group III, combined treatment including a single periurethral injection of NCLHA plus CaHA followed by four vaginal applications of RF at intervals of 3-5 days. The clinical effects of the treatments were evaluated by ICIQ-LUTSqol (Polish version) and UDI-6. Results: The obtained results suggest that the symptoms of SUI and the quality of life of the patients improved significantly in each group after the therapies compared to the pre-treatment levels and were more persistent in the third HA + RF group compared to the HA or the RF group.
引用
收藏
页数:11
相关论文